60 Degrees Pharmaceuticals, Inc. SEC filings SXTPW
60 Degrees Pharmaceuticals, Inc. has 222 filings in SEC EDGAR's recent list, going back to Oct 18, 2022. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Jul 2, 2026 | Aug 5, 2026 |
| PRE 14A | Preliminary proxy statement | Jun 8, 2026 | Jun 8, 2026 |
| DEF 14A | Proxy statement | Aug 27, 2025 | Oct 8, 2025 |
| PRE 14A | Preliminary proxy statement | Aug 15, 2025 | Aug 15, 2025 |
| DEF 14A | Proxy statement | Oct 15, 2024 | Nov 6, 2024 |
| PRE 14A | Preliminary proxy statement | Oct 2, 2024 | Oct 2, 2024 |
| DEF 14A | Proxy statement | May 30, 2024 | Jul 16, 2024 |
| PRE 14A | Preliminary proxy statement | May 3, 2024 | May 3, 2024 |
Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SXTP (Nasdaq), SXTPW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Washington, DC
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1946563
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.